The price of success? Pharmaceutical IP and global healthcare: a positive alliance

Pharma has struggled with the dilemma of drug pricing and patent enforcement in developing countries for decades. In an ideal world, everyone has access to quality health services without financial hardship, but, in the real world, not every country has a strong, efficient and well-run health system. In the past, pharmaceutical companies have been named and shamed for focusing on the richer countries that can afford to pay the prices needed to recoup high R&D costs – but things may be changing